GridAI Technologies Corp. (NasdaqCM: GRDX)
Health Care · Biotechnology · GB
$4.06
-2.64% today · -5.9% 1Y
GridAI Technologies Corp. (NasdaqCM: GRDX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $29.53M and employs 2 people.
Over the last twelve months the share price has lost 5.9%, trading between 1.87 and 6.93.
GRDX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $29.53M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $6.93
- 52-week low
- $1.87
- Avg volume (3M)
- —
- Shares outstanding
- 7.08M
- Employees
- 2
- Next earnings
- —
About GridAI Technologies Corp.
GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.
- ISIN
- US33749P5070
- Listed since
- Oct 11, 2016
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.